Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How does iron rich food intake impact lipitor's efficacy?When will there be a generic loreev available?Pramlintide approval date?Dabrafenib btd date 2023?What are the most memorable drug brands in oral factor b inhibitors? in united states
See the DrugPatentWatch profile for pembrolizumab
Pembrolizumab is an antibody that targets the programmed death-1 (PD-1) receptor on immune cells. The ligand for PD-1 is PD-L1 (also called B7-H1). Sources: 1. DrugPatentWatch.com – Pembrolizumab (Keytruda) drug information
Other Questions About Pembrolizumab :